Key PointsSubstantial revenue from its flagship drug Casgevy should be right around the corner.
Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.
Veytics Intelligence
Citi Sees 60% Upside in CRISPR Therapeutics. Here's What Has to Go Right.
